Vycor Medical, Inc. (VYCO)
0.0672
0.00 (0.00%)
USD |
OTCM |
Sep 10, 16:00
Vycor Medical Enterprise Value : 3.042M for Sept. 10, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 10, 2026 | 3.042M |
| September 09, 2026 | 3.035M |
| September 08, 2026 | 3.035M |
| September 04, 2026 | 3.035M |
| September 03, 2026 | 3.035M |
| September 02, 2026 | 3.035M |
| September 01, 2026 | 3.035M |
| August 31, 2026 | 3.035M |
| August 28, 2026 | 3.035M |
| August 27, 2026 | 2.931M |
| August 26, 2026 | 2.634M |
| August 25, 2026 | 2.634M |
| August 24, 2026 | 3.068M |
| August 21, 2026 | 3.068M |
| August 20, 2026 | 3.068M |
| August 19, 2026 | 2.467M |
| August 18, 2026 | 3.102M |
| August 17, 2026 | 3.102M |
| August 14, 2026 | 3.102M |
| August 13, 2026 | 3.102M |
| August 12, 2026 | 3.102M |
| August 11, 2026 | 3.102M |
| August 10, 2026 | 3.102M |
| August 07, 2026 | 3.102M |
| August 06, 2026 | 3.102M |
| Date | Value |
|---|---|
| August 05, 2026 | 3.102M |
| August 04, 2026 | 3.102M |
| August 03, 2026 | 3.102M |
| July 31, 2026 | 3.102M |
| July 30, 2026 | 3.102M |
| July 29, 2026 | 3.102M |
| July 28, 2026 | 3.102M |
| July 27, 2026 | 3.102M |
| July 24, 2026 | 3.102M |
| July 23, 2026 | 3.102M |
| July 22, 2026 | 3.102M |
| July 21, 2026 | 3.102M |
| July 20, 2026 | 3.102M |
| July 17, 2026 | 3.102M |
| July 16, 2026 | 3.102M |
| July 15, 2026 | 3.102M |
| July 14, 2026 | 3.102M |
| July 13, 2026 | 3.102M |
| July 10, 2026 | 2.701M |
| July 09, 2026 | 2.916M |
| July 08, 2026 | 2.916M |
| July 07, 2026 | 2.916M |
| July 06, 2026 | 2.916M |
| July 02, 2026 | 2.916M |
| July 01, 2026 | 3.000M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 206.51B |
| AngioDynamics, Inc. | 592.61M |
| Alphatec Holdings, Inc. | 1.859B |
| AtriCure, Inc. | 2.600B |
| Baxter International, Inc. | 19.18B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.0191M |
| Revenue (Quarterly) | 0.4183M |
| Total Expenses (Quarterly) | 0.4374M |
| EPS Diluted (Quarterly) | -0.0007 |
| Gross Profit Margin (Quarterly) | 78.80% |
| Profit Margin (Quarterly) | -4.57% |
| Earnings Yield | -17.26% |
| Operating Earnings Yield | 2.15% |
| Normalized Earnings Yield | -17.11 |